Shares of 89bio, Inc. (NASDAQ:ETNB – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the seven research firms that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month […]
89bio (NASDAQ:ETNB – Get Free Report) and 2seventy bio (NASDAQ:TSVT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, risk, valuation, earnings, analyst recommendations, profitability and dividends. Profitability This table compares 89bio and 2seventy bio’s […]
89bio, Inc. (NASDAQ:ETNB – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six brokerages that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price target among […]
89bio (NASDAQ:ETNB – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $31.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 171.45% from the […]
89bio (NASDAQ: ETNB) has recently received a number of price target changes and ratings updates: 3/6/2024 – 89bio had its price target raised by analysts at Evercore ISI from $29.00 to $37.00. They now have an “outperform” rating on the stock. 3/5/2024 – 89bio had its “market perform” rating reaffirmed by analysts at Oppenheimer Holdings […]